Russell Investments Group Ltd. Has $390,000 Position in Schrodinger, Inc. $SDGR

Key Points

• Russell Investments Group Ltd. significantly reduced its stake in Schrodinger, Inc. by 84.3%, holding only 19,746 shares after selling a large number of shares in the first quarter.
• Several hedge funds have fluctuated their positions in Schrodinger, with Stephens Investment Management Group and GAMMA Investing LLC notably increasing their stakes by 22.5% and 4,213.0% respectively during the same period.
• Analysts have recently downgraded Schrodinger's stock ratings, with Morgan Stanley and Citigroup lowering their price targets to $19.00 and $20.00, while the average rating remains a "Moderate Buy".

Russell Investments Group Ltd. lessened its holdings in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) by 84.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,746 shares of the company's stock after selling 106,322 shares during the quarter. Russell Investments Group Ltd.'s holdings in Schrodinger were worth $390,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in SDGR. Raymond James Financial Inc. bought a new stake in shares of Schrodinger in the fourth quarter worth $325,000. MetLife Investment Management LLC lifted its position in shares of Schrodinger by 5.6% in the fourth quarter. MetLife Investment Management LLC now owns 34,554 shares of the company's stock worth $667,000 after purchasing an additional 1,825 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Schrodinger by 8.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 42,009 shares of the company's stock worth $811,000 after purchasing an additional 3,376 shares in the last quarter. Northern Trust Corp lifted its position in shares of Schrodinger by 11.3% in the fourth quarter. Northern Trust Corp now owns 602,618 shares of the company's stock worth $11,625,000 after purchasing an additional 60,987 shares in the last quarter. Finally, BNP Paribas Financial Markets bought a new stake in shares of Schrodinger in the fourth quarter worth $330,000. Institutional investors own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on SDGR shares. Wall Street Zen lowered shares of Schrodinger from a "hold" rating to a "sell" rating in a research report on Saturday, August 30th. Morgan Stanley lowered their target price on shares of Schrodinger from $28.00 to $19.00 and set an "equal weight" rating on the stock in a report on Monday, August 18th. Barclays started coverage on shares of Schrodinger in a report on Thursday, August 14th. They set an "overweight" rating and a $25.00 target price on the stock. KeyCorp lowered their target price on shares of Schrodinger from $32.00 to $30.00 and set an "overweight" rating on the stock in a report on Monday, July 14th. Finally, Citigroup downgraded shares of Schrodinger from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $35.00 to $20.00 in a report on Friday, August 15th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $27.83.

Schrodinger Trading Up 0.8%

Shares of NASDAQ:SDGR traded up $0.16 on Friday, hitting $19.13. The company had a trading volume of 1,104,317 shares, compared to its average volume of 1,208,495. Schrodinger, Inc. has a 1-year low of $16.60 and a 1-year high of $28.47. The stock has a market cap of $1.41 billion, a price-to-earnings ratio of -7.71 and a beta of 1.79. The stock has a 50 day moving average price of $20.40 and a 200 day moving average price of $21.77.

Schrodinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.59) EPS for the quarter, beating the consensus estimate of ($0.83) by $0.24. Schrodinger had a negative net margin of 76.22% and a negative return on equity of 45.70%. The firm had revenue of $54.76 million for the quarter, compared to the consensus estimate of $52.03 million. During the same period in the previous year, the company earned ($0.66) earnings per share. The company's quarterly revenue was up 15.7% on a year-over-year basis. Sell-side analysts anticipate that Schrodinger, Inc. will post -2.37 earnings per share for the current fiscal year.

Schrodinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.